Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 12:45 AM
NCT ID: NCT01535560
Description: This reporting group includes all participants who received study drug. Adverse events were obtained as solicited comments from the study patients and as observations by the study investigator.
Frequency Threshold: 5
Time Frame: Adverse events were collected for the duration of the study (6 months).
Study: NCT01535560
Study Brief: Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vehicle AL-60371 Vehicle, 4 drops in the affected ear(s) twice daily for 7 days None None 0 274 0 274 View
AL-60371 AL-60371, 0.3% otic suspension, 4 drops in the affected ear(s) twice daily for 7 days None None 0 274 0 274 View
Serious Events(If Any):
Other Events(If Any):